Pune, India, October 2019, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Automated Cell Culture Equipment Market.
Automated Cell Culture Equipment Market is estimated to be valued at USD 4,906.53 Million by 2025 and is expected to register a CAGR of 12.04% during the forecast period.
Automated cell culture equipment aids in maximizing accuracy, precision, and minimizes time and consumable costs. The global automated cell culture equipment market is witnessing a significant market growth due to enhanced productivity and good quality of cell lines than manual cell culture equipment.
The growing research & development (R&D) initiatives in the pharmaceutical industry, rise in adoption of liquid handling systems, and increasing prevalence of cancer and other infectious diseases are expected to drive the growth of this market during the forecast period. However, high maintenance costs, lack of awareness, and shortage of skilled professionals are restraining the growth of the market. The increasing focus on regenerative medicine is likely to create an opportunity for the growth of the global automated cell culture equipment market.
The Global Automated Cell Culture Equipment Market has been segmented into lab automation type, product type, application, and end-user.
Based on the lab automation type, the global automated cell culture equipment market has been segmented into modular automation and whole lab automation. The modular automation segment accounted for the largest market share of 67.20% in 2018, with a market value of USD 1484.16 million, which is projected to register a CAGR of 11.68% during the forecast period. On the basis of product type, the global automated cell culture equipment market has been classified into consumables, equipment, and software.
Based on application, the global automated cell culture equipment market is segmented into biopharmaceutical production, tissue engineering, vaccine production, drug screening and development, gene therapy & regenerative medicine, stem cell therapy, toxicity testing, diagnostics, and others.
On the basis of end-user, the global automated cell culture equipment market has been segmented into pharmaceutical & biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories, and others.
The global automated cell culture equipment market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The existence of key market players, a well-developed healthcare infrastructure, significant per capita healthcare spending, high funding for research & development, focused research on cancer along with grants from government healthcare agencies, and high adoption of advanced medical technologies in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. According to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases are expected to be diagnosed. The US expenditure for cancer care was approximately USD 147.3 billion in 2017. This high incidence of cancer cases and growing investment in R&D to develop new treatment options is expected to drive the American automated cell culture equipment market during the forecast period.
Access Report Details @ https://www.marketresearchfuture.com/reports/automated-cell-culture-equipment-market-8770
Market Research Future (MRFR) recognizes Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens as the key players in the global automated cell culture equipment market.
Key Findings of the Study